This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Aug 1;175(8):870-871.

doi: 10.1001/jamapediatrics.2021.1068.

Inadequate Dosage of Mycophenolate Mofetil Is Likely to Yield Substandard Trial Results and Substandard Patient Care-Reply

Andrea Angeletti¹, Pietro Ravani², Gian Marco Ghiggeri^{1

3}

Affiliations

Affiliations

¹ Division of Nephrology, Dialysis and Transplantation, Istituto Giannina Gaslini IRCCS, Genoa, Italy.
² Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
³ Laboratory on Molecular Nephrology, Istituto Giannina Gaslini IRCCS, Genoa, Italy.

PMID: 34028511
DOI: 10.1001/jamapediatrics.2021.1068

Comment

Inadequate Dosage of Mycophenolate Mofetil Is Likely to Yield Substandard Trial Results and Substandard Patient Care-Reply

Andrea Angeletti et al. JAMA Pediatr. 2021.

. 2021 Aug 1;175(8):870-871.

doi: 10.1001/jamapediatrics.2021.1068.

Authors

Andrea Angeletti¹, Pietro Ravani², Gian Marco Ghiggeri^{1

3}

Affiliations

¹ Division of Nephrology, Dialysis and Transplantation, Istituto Giannina Gaslini IRCCS, Genoa, Italy.
² Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
³ Laboratory on Molecular Nephrology, Istituto Giannina Gaslini IRCCS, Genoa, Italy.

PMID: 34028511
DOI: 10.1001/jamapediatrics.2021.1068

No abstract available

PubMed Disclaimer

Comment on

Rituximab vs Low-Dose Mycophenolate Mofetil in Recurrence of Steroid-Dependent Nephrotic Syndrome in Children and Young Adults: A Randomized Clinical Trial.
Ravani P, Lugani F, Drovandi S, Caridi G, Angeletti A, Ghiggeri GM. Ravani P, et al. JAMA Pediatr. 2021 Jun 1;175(6):631-632. doi: 10.1001/jamapediatrics.2020.6150. JAMA Pediatr. 2021. PMID: 33616641 Free PMC article. Clinical Trial.
Inadequate Dosage of Mycophenolate Mofetil Is Likely to Yield Substandard Trial Results and Substandard Patient Care.
Schreuder MF, Ehren R, Weber LT. Schreuder MF, et al. JAMA Pediatr. 2021 Aug 1;175(8):869-870. doi: 10.1001/jamapediatrics.2021.1071. JAMA Pediatr. 2021. PMID: 34028491 No abstract available.
Inadequate Dosage of Mycophenolate Mofetil Is Likely to Yield Substandard Trial Results and Substandard Patient Care.
Belluzzi B, Bossini B, Pennesi M. Belluzzi B, et al. JAMA Pediatr. 2021 Aug 1;175(8):870. doi: 10.1001/jamapediatrics.2021.1074. JAMA Pediatr. 2021. PMID: 34028501 No abstract available.

Similar articles

Inadequate Dosage of Mycophenolate Mofetil Is Likely to Yield Substandard Trial Results and Substandard Patient Care.
Belluzzi B, Bossini B, Pennesi M. Belluzzi B, et al. JAMA Pediatr. 2021 Aug 1;175(8):870. doi: 10.1001/jamapediatrics.2021.1074. JAMA Pediatr. 2021. PMID: 34028501 No abstract available.
Inadequate Dosage of Mycophenolate Mofetil Is Likely to Yield Substandard Trial Results and Substandard Patient Care.
Schreuder MF, Ehren R, Weber LT. Schreuder MF, et al. JAMA Pediatr. 2021 Aug 1;175(8):869-870. doi: 10.1001/jamapediatrics.2021.1071. JAMA Pediatr. 2021. PMID: 34028491 No abstract available.
Clinical pharmacokinetics of mycophenolate mofetil.
Bullingham RE, Nicholls AJ, Kamm BR. Bullingham RE, et al. Clin Pharmacokinet. 1998 Jun;34(6):429-55. doi: 10.2165/00003088-199834060-00002. Clin Pharmacokinet. 1998. PMID: 9646007 Review.
Pharmacokinetics of mycophenolate sodium and comparison with the mofetil formulation in stable kidney transplant recipients.
Cattaneo D, Cortinovis M, Baldelli S, Bitto A, Gotti E, Remuzzi G, Perico N. Cattaneo D, et al. Clin J Am Soc Nephrol. 2007 Nov;2(6):1147-55. doi: 10.2215/CJN.02820707. Epub 2007 Oct 10. Clin J Am Soc Nephrol. 2007. PMID: 17928466 Clinical Trial.
Mycophenolate mofetil: a unique immunosuppressive agent.
Hood KA, Zarembski DG. Hood KA, et al. Am J Health Syst Pharm. 1997 Feb 1;54(3):285-94. doi: 10.1093/ajhp/54.3.285. Am J Health Syst Pharm. 1997. PMID: 9028422 Review.

See all similar articles

Cited by

Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
Larkins NG, Hahn D, Liu ID, Willis NS, Craig JC, Hodson EM. Larkins NG, et al. Cochrane Database Syst Rev. 2024 Nov 8;11(11):CD002290. doi: 10.1002/14651858.CD002290.pub6. Cochrane Database Syst Rev. 2024. PMID: 39513526

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations